Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2153726 | Nuclear Medicine and Biology | 2013 | 9 Pages |
Abstract
The low reactivity of the studied cyclooctynes, and their serum interactions preclude their use at the low in vivo concentrations typical for pretargeting applications.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
S.M. van den Bosch, R. Rossin, P. Renart Verkerk, W. ten Hoeve, H.M. Janssen, J. Lub, M.S. Robillard,